循环肿瘤细胞在食管癌治疗中的研究进展
Research Progress on Circulating Tumor Cells in the Treatment of Esophageal Cancer
DOI: 10.12677/ACM.2022.12111408, PDF,   
作者: 胡海洋：青海大学研究生院，青海 西宁 ；林明哲*：青海大学附属医院，青海 西宁
关键词: 循环肿瘤细胞；食管癌；应用；预后；Circulating Tumor Cell； Esophageal Cancer； Application； Prognosis
摘要: 食管腺癌(EC)是一种高度侵袭性的癌症，通常在晚期被诊断出来。近年来，其发病率大幅增加，迫切需要新的诊断、预后和预测性生物标志物。CTC是从原发性或转移性肿瘤脱落到外周循环中的细胞。大多数CTC将被人体免疫系统清除，而少数幸存的CTC可以通过血液到达身体的其他部位，导致肿瘤转移。初步研究结果表明，CTC在EC的所有阶段都可以代表一种有效的、非侵入性的、实时可评估的生物标志物。本文将对目前CTC在食管癌中的应用进行总结，以确认CTC的临床有用性。
Abstract: Esophageal adenocarcinoma (EC) is a highly aggressive cancer that is usually diagnosed at an ad-vanced stage. Its incidence has increased dramatically in recent years, and new diagnostic, prog-nostic and predictive biomarkers are urgently needed. CTCs are cells shed into the peripheral cir-culation from primary or metastatic tumors. Most CTCs will be cleared by the body’s immune sys-tem, while the few that survive can travel through the bloodstream to other parts of the body, caus-ing tumors to metastasize. Preliminary findings suggest that CTCs can represent an effective, non-invasive, and real-time evaluable biomarker in all stages of EC. This article will summarize the cur-rent application of CTCs in esophageal cancer to confirm the clinical usefulness of CTCs.
文章引用：胡海洋, 林明哲. 循环肿瘤细胞在食管癌治疗中的研究进展[J]. 临床医学进展, 2022, 12(11): 9769-9773. https://doi.org/10.12677/ACM.2022.12111408

参考文献

[1] Freddie, B., Jacques, F., Isabelle, S., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Abnet, C.C., Arnold, M. and Wei, W.Q. (2018) Epidemiology of Esopha-geal Squamous Cell Carcinoma. Gastroenterology, 154, 360-373. [Google Scholar] [CrossRef] [PubMed]
[3] Dianat-Moghadam, H., Azizi, M., Eslami, S.Z., Cor-tés-Hernández, L.E., Heidarifard, M., Nouri, M. and Alix-Panabières, C. (2020) The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance. Cancers (Basel), 12, Article No. 867. [Google Scholar] [CrossRef] [PubMed]
[4] Pantel, K. and Alix-Panabières, C. (2016) Functional Studies on Vi-able Circulating Tumor Cells. Clinical Chemistry, 62, 328-334. [Google Scholar] [CrossRef] [PubMed]
[5] Ilie, M., Hofman, V., Long-Mira, E., Selva, E., Vignaud, J.-M., Padovani, B., Mouroux, J., Marquette, C.-H. and Hofman, P. (2014) “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. PLOS ONE, 9, e111597. [Google Scholar] [CrossRef] [PubMed]
[6] Ashworth, T.R. (1869) A Case of Cancer in Which Cells Simi-lar to Those in the Tumors Were Seen in the Blood after Death. Australasian Medical Journal, 14, 146-149.
[7] Pantel, K. and Speicher, M.R. (2016) The Biology of Circulating Tumor Cells. Oncogene, 35, 1216-1224. [Google Scholar] [CrossRef] [PubMed]
[8] Alix-Panabieres, C. and Pantel, K. (2014) Challenges in Circulating Tumour Cell Research. Nature Reviews Cancer, 14, 623-631. [Google Scholar] [CrossRef] [PubMed]
[9] Wu, T., Cheng, B. and Fu, L. (2017) Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives. Molecular Pharmacology, 92, 232-239. [Google Scholar] [CrossRef] [PubMed]
[10] Qiao, Y., Li, J., Shi, C., et al. (2017) Prognostic Value of Circulating Tumor Cells in the Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy, 10, 1363-1373. [Google Scholar] [CrossRef] 
[11] Chen, W., Li, Y., Yuan, D., Peng, Y. and Qin, J. (2018) Practical Value of Identifying Circulating Tumor Cells to Evaluate Esophageal Squamous Cell Carcinoma Staging and Treatment Efficacy. Thoracic Cancer, 9, 956-966. [Google Scholar] [CrossRef] [PubMed]
[12] Qiao, Y.Y., Lin, K.X., Zhang, Z., Zhang, D.J., Shi, C.H., Xiong, M., Qu, X.H. and Zhao, X.H. (2015) Monitoring Disease Progression and Treatment Efficacy with Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma: A Case Report. World Journal of Gastroenterology, 21, 7921-7928. [Google Scholar] [CrossRef] [PubMed]
[13] Matsushita, D., Uenosono, Y., Arigami, T., et al. (2015) Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. An-nals of Surgical Oncology, 22, 3674-3680. [Google Scholar] [CrossRef] [PubMed]
[14] Xu, H.T., Miao, J., Liu, J.W., Zhang, L.G. and Zhang, Q.G. (2017) Prognostic Value of Circulating Tumor Cells in Esophageal Cancer. World Journal of Gastroenterology, 23, 1310-1318. [Google Scholar] [CrossRef] [PubMed]
[15] Li, Y., Wu, G., Yang, W., Wang, X., Duan, L., Niu, L., Zhang, Y., Liu, J., Hong, L. and Fan, D. (2020) Prognostic Value of Circulating Tumor Cells Detected with the Cell Search System in Esophageal Cancer Patients: A Systematic Review and Meta-Analysis. BMC Cancer, 20, Article No. 581. [Google Scholar] [CrossRef] [PubMed]
[16] Lindsay, C.R., Blackhall, F.H., Carmel, A., Fernan-dez-Gutierrez, F., Gazzaniga, P., Groen, H.J.M., et al. (2019) EPAC-Lung: Pooled Analysis of Circulating Tumour Cells in Advanced Non-Small Cell Lung Cancer. European Journal of Cancer, 117, 60-68. [Google Scholar] [CrossRef] [PubMed]
[17] Zou, K., Yang, S., Zheng, L., Wang, S. and Xiong, B. (2016) Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis. BioMed Research International, 2016, Article ID: 2765464. [Google Scholar] [CrossRef] [PubMed]
[18] Esmaeilsabzali, H., Beischlag, T.V., Cox, M.E., Parameswaran, A.M. and Park, E.J. (2013) Detection and Isolation of Circulating Tumor Cells: Principles and Methods. Biotechnology Ad-vances, 31, 1063-1084. [Google Scholar] [CrossRef] [PubMed]
[19] Campos-Carrillo, A., Weitzel, J.N., Sahoo, P., et al. (2020) Circulating Tumor DNA as an Early Cancer Detection Tool. Pharmacology & Therapeutics, 207, Article ID: 107458. [Google Scholar] [CrossRef] [PubMed]
[20] Schiffman, J.D., Paul, M., Fisher, G. and Gibbs, P. (2015) Early Detection of Cancer: Past, Present, and Future. American Society of Clinical Oncology Educational Book, 35, 57-65.
[21] Habli, Z., Al Chamaa, W. and Saab, R. (2020) Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities. Cancers (Basel), 12, Article No. 1930. [Google Scholar] [CrossRef] [PubMed]
[22] Feng, Z., Wu, J., Lu, Y., Chan, Y.T., Zhang, C., Wang, D., Luo, D., Huang, Y., Feng, Y. and Wang, N. (2022) Circulating Tumor Cells in the Early Detection of Human Cancers. Interna-tional Journal of Biological Sciences, 18, 3251-3265. [Google Scholar] [CrossRef] [PubMed]

为你推荐